News
Prediction: This AI Stock Could Quietly Outperform Wall Street Favorites
Artificial intelligence (AI) stocks have been in fine form on the stock market in 2025, and this is evident from the healthy gains of 21% clocked by the tech-laden Nasdaq Composite index so far this
Vanguard VGIT vs iShares IEI: Understanding the Stability Behind Each Strategy
iShares 3-7 Year Treasury Bond ETF (NASDAQ:IEI) and Vanguard Intermediate-Term Treasury ETF (NASDAQ:VGIT) both target U.S. Treasuries in the intermediate maturity range, but differ on cost, yield
Jensen Huang Just Delivered Incredible News for Nvidia and AI Stock Investors
In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA) and other artificial intelligence stocks. To learn more, check out the short video, consider subscribing, and click the
Why Robinhood Stock Just Crashed
Robinhood Markets (NASDAQ: HOOD), the online brokerage that shook up stock market trading during the pandemic and has only grown stronger since, took a sudden turn for the worse Thursday, falling
Why Oddity Tech Stock Rallied Today
Shares of Oddity Tech (NASDAQ: ODD) rose on Thursday after the skincare specialist delivered third-quarter earnings that surpassed investors' expectations.
As of 12:20 p.m. EST, Oddity's stock price
Why Astera Labs Stock Rocketed Higher Today
When analysts wax bullishly about stocks, investors often sit up and take notice. That dynamic is playing out clearly today with Astera Labs (NASDAQ: ALAB), a specialist in artificial intelligence
Why Iren Stock Surged Higher Today
After rocketing higher by as much as 678% this year, investors had been dumping shares of Iren Limited (NASDAQ: IREN) in recent weeks. Shares of the artificial intelligence (AI) infrastructure
Warren Buffett's Berkshire Hathaway Just Bought One of My Favorite Stocks. Is It Time to Pile In?
Any time Warren Buffett's Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) adds a new investment to its stock portfolio, it tends to grab attention. And because Berkshire has been much more of a
Why Palantir Technologies Rallied Thursday Morning
Palantir Technologies (NASDAQ: PLTR) stock gained ground today, climbing as much as 5.5%. As of 11:15 a.m. ET, the stock was still up 1.8%.
The artificial intelligence (AI) software and data mining
Investment Powerhouse Backs Biotech Stock to the Tune of $419 Million
Bain Capital Life Sciences Investors, LLC reported a new stake in HeartFlow, Inc. (NASDAQ:HTFL), adding 12,448,158 shares valued at approximately $419.00 million, according to a November 14, 2025
Nvidia Stock Jumped on Staggering Growth and CEO Jensen Huang's Bullish Comments. Is the Stock a Buy?
Shares of Nvidia (NASDAQ: NVDA) rose as much as 5.1% on Thursday after the AI (artificial intelligence) chip designer posted another blowout quarter and offered upbeat guidance. Investors also
This Small Grocer That 1 Analyst Calls His Best Retail Stock Just Posted Another Blowout Quarter
Unless you stumbled across this article with a specific ticker symbol search, there's a good chance that you've never heard of BBB Foods (NYSE: TBBB). That's fair. Despite operating a chain of 3,162
Why Magnera Stock Exploded Higher Today
Magnera (NYSE: MAGN), which manufactures absorbent hygiene products, protective apparel, wipes, and specialty construction products, reported strong sales and "record" cash from operations last
Why Jack In The Box Stock Popped Today
Jack in the Box's (NASDAQ: JACK) shares rose as much as 12% on Thursday after the fast-food chain reported fiscal fourth-quarter results and outlined expectations for fiscal 2026. The stock is still
This Ridiculously Cheap Warren Buffett Stock Could Make You Richer
It would've been shocking to see the names Warren Buffett and Sirius XM Holdings (NASDAQ: SIRI) mentioned in the same sentence in the early years of satellite radio. Sirius XM was a speculative
SYON Capital Loads Up 132,000 Shares of iShares MSCI China ETF Worth $11.7 Million
SYON Capital LLC recently disclosed that it added shares of the iShares MSCI China ETF (NASDAQ:MCHI), increasing its position by $11,688,425 according to a recent SEC filing.
According to a recent
EQS-News: CTS EVENTIM: Profitable growth in the third quarter
Why Bath & Body Works Stock Cratered Today
Shares of Bath & Body Works (NYSE: BBWI) fell as much as 25.7% on Thursday after the specialty retailer posted disappointing third-quarter results and slashed its full-year outlook. The move came
Why Did Nvidia Stock Soar Today?
It didn't take long for Nvidia (NASDAQ: NVDA) to dispel fears of a slowdown in artificial intelligence (AI) infrastructure spending. Its latest earnings report was stellar, and investors are
This One Tech Stock Is Crushing the Entire Sector. Should You Invest?
The S&P 500 technology sector was down 4.8% over the past week, and just about every one of the 69 stocks in the sector was also in the red over the week. (Just two other stocks in the sector were
Is NuScale Power Stock's Big Price Drop an Opportunity to Buy?
According to a Securities and Exchange Commission (SEC) filing dated November 14, 2025, Samsung C&T Corp increased its holdings in NuScale Power Corporation (NYSE:SMR) by 2,578,702 shares during the
Maximus (MMS) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, Nov. 20, 2025 at 9 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
2 Inflation-Proof Growth Stocks That Could Outperform the Market
Inflation can be a significant problem for investors in at least two ways. First, the rise in prices leads to increased costs and expenses for corporations, as well as decreased consumer spending
Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer
On November 14, 2025, Bain Capital Life Sciences Investors, LLC disclosed a purchase of 520,310 shares of Cidara Therapeutics (NASDAQ:CDTX), increasing its position value by approximately $167.48
Merck Is Buying Cidara Therapeutics for $9.2 Billion. Is This the Boost the Lagging Drugmaker Needs?
Over the past two years, Merck (NYSE: MRK) has faced several challenges, resulting in a decline in the company's share price. Even worse, the pharmaceutical giant could face more issues ahead



